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Ubiquitination is a reversible protein modification broadly implicated in cellular functions.
Signaling processes mediated by ubiquitin (ub) are crucial for the cellular response to
DNA double-strand breaks (DSBs), one of the most dangerous types of DNA lesions.
In particular, the DSB response critically relies on active ubiquitination by the RNF8
and RNF168 ub ligases at the chromatin, which is essential for proper DSB signaling
and repair. How this pathway is fine-tuned and what the functional consequences
are of its deregulation for genome integrity and tissue homeostasis are subject of
intense investigation. One important regulatory mechanism is by reversal of substrate
ubiquitination through the activity of specific deubiquitinating enzymes (DUBs), as
supported by the implication of a growing number of DUBs in DNA damage response
processes. Here, we discuss the current knowledge of how ub-mediated signaling at
DSBs is controlled by DUBs, with main focus on DUBs targeting histone H2A and on
their recent implication in stem cell biology and cancer.
Keywords: ubiquitin, DNA double-strand breaks (DSBs), deubiquitinating enzymes (DUBs), histone H2A,
chromatin, DNA damage response (DDR), hematopoietic stem cell (HSC), cancer
Introduction
The ability of cells to maintain the integrity of their genome is crucial for organism
physiology, including stem cell and tissue homeostasis and cancer avoidance (Jackson and
Bartek, 2009; Blanpain et al., 2011; Behrens et al., 2014). A complex surveillance network
protects cells from the continuous threat of exogenous as well as endogenously generated
genotoxic insults. This includes multiple pathways, collectively called the DNA damage response
(DDR), which ensure eﬀective DNA damage detection, signaling, and repair (Ciccia and Elledge,
2010). DDR coordinates DNA repair with vital cellular functions, including transcription and
DNA replication, and determines the fate of the cell after DNA damage. Post-translational
modiﬁcation of proteins by the 76 amino acid protein ubiquitin (ub) plays a central role in
various aspects of DDR (Lukas et al., 2011; Jackson and Durocher, 2013). ub is conjugated
to lysine residues (Lys, K) in target proteins through the activities of E1, E2, and E3
enzymes (Komander and Rape, 2012). Proteins can be modiﬁed with one ub moiety (mono-
ubiquitination) or with polymeric ub chains. The use of one of the seven lysines of ub (K6,
K11, K27, K29, K33, K48, and K63) or the N-terminal amine (“linear”) for chain formation
Abbreviations: BM, bone marrow; FA, Fanconi anemia; HR, homologous recombination; HSC, hematopoietic stem cell;
HSPC, hematopoietic stem and progenitor cell; IRIFs, ionizing radiation induced foci; K63-ub, lysine 63-linked ubiquitin
chains; PAR, poly(ADP-ribose); PARP, poly(ADP-ribose) polymerase; PcG, polycomb group protein; ub, ubiquitin; uH2A,
mono-ubiquitinated histone H2A; uH2B, mono-ubiquitinated histone H2B.
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allows diverse conformations, conferring a great signaling
potential to the ub system. The resulting ub “code” can target the
substrate for degradation, or regulate its interactions, localization
or activity. Typically, K48-linked ub chains serve as proteasomal
degradation signals, while K63-linked chains (K63-ub) are non-
degradative. The ub code is ultimately “read” by proteins
endowed with ub binding domains, which determine distinct
outcomes in the cell (Komander and Rape, 2012).
Modiﬁcation by ub is regulated by the catalytic activities of
deubiquitinating enzymes (DUBs; also known as deubiquitinases
or deubiquitylating enzymes), which can cleave ub from
proteins or process all types of ub-chains (Komander et al.,
2009). The human genome encodes for ≈90 potential DUBs,
many of which are strongly implicated in cancer and other
pathologies, including neurodegenerative, hematological and
infectious diseases (Nijman et al., 2005; Komander et al., 2009).
DUBs can be subdivided in ﬁve subfamilies, four belonging
to the cysteine proteases group [ubiquitin-speciﬁc proteases
(USPs), ovarian tumor proteases (OTUs), ubiquitin C-terminal
hydrolases (UCHs) and Josephin domain DUBs], and one
consisting of the JAMM/MPN+ family of metalloproteases
(Komander et al., 2009). One key function of DUBs is the
generation of free ub from ub precursors. Second, by cleaving
mono-ub adducts or poly-ub chains from target proteins, DUBs
can reverse a non-degradative ub signal or stabilize target
proteins by rescuing them from proteasomal or lysosomal
degradation. Third, DUBs can cleave the isopeptide bond from
within the ub polymer, an activity that allows editing ub chains
and thereby ub-mediated signal (Komander and Rape, 2012;
Heride et al., 2014). Beside the catalytic domain, DUBs contain
multiple domains, some of which aid in substrate or in protein–
protein interactions, endowing the DUBs with the ability to
display speciﬁcity at the protein substrate level as well as at the
level of ub chain types (Komander and Rape, 2012).
It has become clear that reversal of substrate ubiquitination
by DUBs is a critical regulatory mechanism throughout the
DDR. In this review, I will focus on recent discoveries involving
DUBs in the modulation of ub-mediated DDR at DNA double-
strand breaks (DSBs), with emphasis on histone H2A targeting
DUBs. Readers are referred to recent reviews for a more
comprehensive overview of DUB functions (Komander et al.,
2009; Clague et al., 2012; Belle and Nijnik, 2014; Sahtoe
and Sixma, 2015), ub and DUBs roles in DDR (Ulrich,
2012; Jackson and Durocher, 2013; Jacq et al., 2013; Brown
and Jackson, 2015) or for detailed information regarding the
ubiquitination/deubiquitination process (Komander and Rape,
2012; Heride et al., 2014).
Ubiquitin-Mediated DDR Signaling at
DNA Double-Strand Breaks
In eukaryotic cells, the packaging of DNA with histone proteins
into chromatin, the basic unit being the nucleosome, has
major impact on DNA damage signaling and repair. This is
because on one hand the compact organization of chromatin
intrinsically limits the degree of access to DNA. At the same time,
however, chromatin provides a sensitive regulatory platform for
DDR through post-translational modiﬁcations to both chromatin
components (i.e., histones) and non-chromatin proteins (Lukas
et al., 2011). Non-proteolytic (mono-) ubiquitination of histones
is a prevalent modiﬁcation in mammalian cells (Goldknopf and
Busch, 1977). Work from several groups has shown that histone
ubiquitination at the chromatin surrounding DSBs is a key step
in DDR activation (Lukas et al., 2011; Figure 1). Phosphorylation
of the histone variant H2AX (yielding γH2AX) by the ataxia
telangectasia mutated (ATM) checkpoint kinase promotes the
binding of the E3 ligase RNF8 through the mediator protein
MDC1 to damage sites, where it initiates ub signaling (Huen et al.,
2007; Kolas et al., 2007; Mailand et al., 2007; Wang and Elledge,
2007). A second E3, RNF168, is then recruited through RNF8-
ubiquitinated substrates to the proximity of the lesion and starts
catalysis of H2A/H2AX ubiquitination on Lys 13 (H2AK13ub)
and/or Lys15 (H2AK15ub; Gatti et al., 2012; Mattiroli et al.,
2012). The coordinated activities of RNF8/RNF168 with HERC2
and the E2 Ubc13 lead to the formation on H2A/H2AX of K63-
ub, a prevalent ub linkage at DSBs (Doil et al., 2009; Pinato et al.,
2009; Stewart et al., 2009; Gatti et al., 2012; Mattiroli et al., 2012).
A major outcome of RNF8/RNF168-mediated ubiquitination is
recruitment/stable accumulation of DDR proteins at the lesion,
with the tumor suppressors BRCA1 (breast cancer 1, early onset)
and 53BP1 (p53 binding protein 1) representing the two key
eﬀectors of the pathway (Lukas et al., 2011). Importantly, the
interplay between BRCA1 and 53BP1 determines eﬀective DSB
repair by one of the two major DSB repair pathways, with
BRCA1 promoting the error-free homologous recombination
(HR) process while 53BP1 committing to non-homologous end
joining (NHEJ; Cao et al., 2009; Bouwman et al., 2010; Bunting
et al., 2010). By inﬂuencing the relative kinetics of these DDR
eﬀectors at DSBs, the RNF8 pathway is functionally implicated
in determining the repair pathway choice, which is critical to
genome maintenance (Panier and Boulton, 2014).
53BP1 recognizes the DSB-speciﬁc H2AK13/15ub mark
through its UDR (ubiquitination-dependent recruitment) motif,
which, together with the Tudor domain reads a bivalent
ubiquitination-methylation signal at damage sites (Fradet-
Turcotte et al., 2013). While no ub-binding domains have
been yet identiﬁed in BRCA1, it is clear that BRCA1 stable
accumulation at the DSB-ﬂanking chromatin is dependent on
its interaction with RAP80, a protein that binds K63-linked ub
conjugates through its tandem ub-interacting motifs (Huen et al.,
2007; Kolas et al., 2007; Mailand et al., 2007; Wang et al., 2007).
Initial BRCA1 recruitment, however, appears independent of
Rap80 (Hu et al., 2011; Yin et al., 2012) and involves binding
of a small fraction of BRCA1 directly at the DNA break through
interaction with the DSB recognition factor Nbs1 (Goldstein and
Kastan, 2015).
Signaling through chromatin ub during DDR is multifaceted,
engaging several E3 ligases and modiﬁcation by ub and ub-like
proteins of (non-)histone proteins (Lukas et al., 2011; Jackson and
Durocher, 2013; Brown and Jackson, 2015). One of these E3 is
the PcG transcriptional repressor complex RING1b/BMI1 (Chou
et al., 2010; Ismail et al., 2010; Gieni et al., 2011; Ginjala et al.,
2011; Vissers et al., 2012). RING1b/BMI1 is part of the polycomb
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FIGURE 1 | The role of deubiquitinating enzymes in the chromatin-based response to DNA double-strand breaks. (A) Recognition of a DNA
double-strand break (DSB) by the MRN (MRE11-RAD50-NBS1) complex initiates DDR signaling, triggering ATM (ataxia-telangectasia mutated)
kinase-dependent phosphorylation of H2AX (γH2AX). ATM phosphorylates also MDC1 (mediator of DNA damage checkpoint protein 1), which is recognized by
the RING finger 8 (RNF8) E3 ligase. The activity of RNF8 is required for recruitment of a second E3, RNF168. RNF168 mono-ubiquitinates H2A-type histones
on Lys13 and Lys15 (H2A(X)K13/K15Ub), and the concerted action of RNF8/RNF168 leads to the formation of K63-linked ubiquitin (Ub) chains on these
lysines and to ubiquitination of other substrates (Y and W). RNF168 can bind to its own products, thereby amplifying chromatin ubiquitination around the DSB.
OTUB1 opposes RNF168 activity in a non-catalytic manner, by binding to the E2 ubiquitin-conjugating enzymes UBC13 and UbcH5. USP3, USP44, and Dub3
DUB activities impair RNF168 recruitment, suggesting that they can target RNF8 substrate(s). These DUBs may also cleave RNF168-mediated ubiquitinated
H2A(X). Excessive RNF168-dependent chromatin ubiquitination is limited by the TRIP12 and UBR5 E3 ligases, which target RNF168 for proteasomal
degradation. USP34, instead, counteracts DSB-induced RNF168 ubiquitination. DSBs also trigger the recruitment of the Polycomb group E3 RING1B/BMI1,
which mono-ubiquitinates H2A on Lys119 (H2AK119Ub) to locally repress transcription. USP16 and BAP1 target the H2AK119Ub mark, and USP16 activity is
required for re-activation of DSB-induced transcriptional silencing. USP3 and USP44 oppose to steady-state mono-ubiquitinated H2A, which is primarily
constituted by H2AK119Ub. (B) DSB-induced ubiquitin signals are recognized by downstream DDR factors. 53BP1 (p53 binding protein 1) recognizes the
H2AK15Ub mark by its UDR (ubiquitination-dependent recruitment) motif, and dimethylated H4K20 (H4K20me2) with its TUDOR domain. One way BRCA1
(Breast cancer 1) is recruited to DSBs is through its interaction with RAP80 (receptor-associated protein 80), a protein that effectively binds K63-ub
conjugates. BRCA1 has E3 ligase activity and functions as a heterodimer with BARD1 (BRCA1-associated RING domain protein 1). The DUBs BRCC36,
POH1, and OTUB2 regulate DDR signaling by hydrolyzing DSB-induced K63-ub chains. OTUB2 also opposes to RNF8-dependent ubiquitination of L3MBTL1
(not shown). Whether MYSM1, which also possesses K63-ub cleavage activity, participates in this step of DDR is an open question. RNF168-mediated
K27-linked ub chains on H2A/H2AX constitute additional DDR signals, and BRCA1/BARD1 catalyzed K6-linked chains (not shown) may also contribute to
DDR. Specific activities that oppose to these atypical ub chains in DDR are not known. 53BP1 and BRCA1 determine effective DSB repair, with 53BP1
committing to NHEJ (non-homologous end joining) and BRCA promoting HR (homologous recombination). Dashed lines indicate proposed protein–protein
interactions. X indicates an unknown RNF8 substrate(s), and Y and W indicate unknown RNF168 substrates. Please refer to the main text for details.
repressive complex 1 (PRC1) and is responsible for the mono-
ubiquitination of H2A at the canonical site, Lys-K119 (yielding
H2AK119ub), a histone mark that constitutes about 10–15%
of H2A under physiological conditions (Goldknopf and Busch,
1977; Wang et al., 2004; Di Croce and Helin, 2013). While the
major source of DSB-induced H2A poly-ubiquitination appears
to be RNF8/RNF168-dependent (Lukas et al., 2011; Mattiroli
et al., 2012), RING1b/BMI1 is required for silencing transcription
in response to neighboring DSBs through local enhancement
of H2A/H2AXK119ub (Ismail et al., 2010; Ginjala et al., 2011;
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Kakarougkas et al., 2014; Ui et al., 2015). RING1b/BMI1 is also
thought to contribute tomaintenance of active ATMatDSBs (Pan
et al., 2011;Wu et al., 2011a). Interestingly, both ubiquitination of
H2AK13/15ub by RNF168 and H2AK119ub by RING1b/BMI1
depend on an intact nucleosome acidic patch (Leung et al.,
2014). It is proposed that this structure within H2A/H2AX serves
as a scaﬀold to integrate diﬀerential signals on H2A (Leung
et al., 2014). In contrast, the functional signiﬁcance of H2AK127-
129ub by the E3 BRCA1/BARD1 is still unclear (Kalb et al.,
2014).
ATM-dependent mono-ubiquitination of histone H2B
(H2BK120ub) also occurs in response to DSBs (Moyal et al.,
2011; Nakamura et al., 2011). Similarly to H2A, H2B mono-
ubiquitination fulﬁlls a dual function, in gene transcription and
in DDR (Shiloh et al., 2011). However, unlike H2AK119ub,
H2BK120ub has been mostly linked to gene activation, in part
through chromatin decompaction at transcribed regions (Shiloh
et al., 2011; Fuchs and Oren, 2014). Transcriptional silencing
and chromatin decondensation are both critical to ensure proper
DNA repair. Given the physical proximity between H2BK120ub
and H2AK13/15ub within the nucleosome, it is possible that
these marks cooperate in the integration of these processes
(Shiloh et al., 2011; Mattiroli et al., 2012; Jackson and Durocher,
2013). To this end, it is relevant the ﬁnding that RNF8 synergizes
with its structurally related kinase CHFR (checkpoint with
fork-head associated and ring ﬁnger) in H2A as well as H2B
ubiquitination, an activity that promotes chromatin relaxation,
ATM activation and genome stability in mice (Wu et al., 2011b).
DNA damage signaling and activation of DNA damage
checkpoints result in transient cell-cycle arrest or permanent cell
cycle withdrawal (Ciccia and Elledge, 2010). An important, yet
not well-understood, aspect of ub-based DDR is how spatio-
temporal control of the signaling is achieved. In particular, it
remains to clarify in full how disassembly of the repair complexes
occurs after the damage has been repaired, which enzymes are
involved and how this impacts on termination of the DNA
damage checkpoint, and ultimately on genomic stability and
survival. Notably, excessive chromatin ub at DSBs associates
with enhanced repair and spreading of gene silencing beyond
the physiological boundaries, underscoring the relevance of tight
control of this pathway (Gudjonsson et al., 2012). Consistently,
several mechanisms have been discovered which modulate
the magnitude of RNF8/RNF168-dependent ubiquitination, and
regulatory inhibition has emerged as an integral DDR component
(Panier and Durocher, 2013). Examples of such mechanisms
include proteolytic ubiquitination of RNF168 (Gudjonsson
et al., 2012), competition for recruitment of RNF168-dependent
eﬀectors by a RNF168 paralog (Panier et al., 2012; Poulsen
et al., 2012), eviction of ubiquitinated proteins (Acs et al., 2011)
and, as reviewed here, DUBs activities at multiple levels of the
RNF8/RNF168 ubiquitination cascade.
Modulation of DSB Signaling by DUBs
Less then a decade ago, studies on the DUBs BRCC36, USP3
and USP16 ﬁrst uncovered the importance of DUB activity in
the modulation of ub-based DDR by regulating recruitment
of RNF168-responsive factors, checkpoint recovery, and DSB-
induced transcriptional silencing, respectively (Nicassio et al.,
2007; Sobhian et al., 2007; Wang and Elledge, 2007; Doil
et al., 2009; Shao et al., 2009; Shanbhag et al., 2010). Since
then, an increasing body of evidence supports the reversal of
DNA damage-induced chromatin ubiquitination by DUBs as a
key aspect of the DSB response (Jackson and Durocher, 2013;
Panier and Durocher, 2013). Indeed, siRNA-based screens in
mammalian cells recently revealed that a great part of the DUB
family has functional connections with the DSB response (Kato
et al., 2014; Nishi et al., 2014; Yu et al., 2014) and a number
of DUBs have been implicated as regulatory components of the
RNF8 pathway (Table 1 and Figure 1). Recent ﬁndings have
broadened the contribution of DUBs targeting histone H2A, the
critical RNF8-RNF168 substrate, to DDR, and will be the main
focus of the next section.
USP3
The ub-speciﬁc protease USP3 is a chromatin-associated protein
endowed with the ability of binding to ubiquitinated H2A
through its Zn ﬁnger UBP domain (Nicassio et al., 2007).
Biochemical and cellular studies showed that both uH2A and
uH2B are relevant USP3 targets (Nicassio et al., 2007; Mosbech
et al., 2013). We recently found that deletion of Usp3 in mice
leads to a measurable increase in uH2A and uH2B in freshly
isolated tissues, suggesting that USP3 has a non-redundant
role in preventing accumulation of uH2A and uH2B in vivo
(Lancini et al., 2014). USP3 is implicated in the regulation of
S-phase progression (Nicassio et al., 2007), a role that may be
relevant also in the context of HSC biology (see below; Lancini
et al., 2014), and in the DSB response. Removal of the ub
mark by USP3 appears important for the prevention and/or
for proper repair of spontaneous DNA damage as well as for
DSB repair and resolution of DDR signaling upon clastogen-
induced DSBs (Nicassio et al., 2007; Lancini et al., 2014; Nishi
et al., 2014). In line with a role for USP3 in the DSB response,
Usp3-deleted HSCs and mice are hypersensitive to IR (Lancini
et al., 2014). Mechanistically, the data suggest that USP3 limits
the RNF8/RNF168 pathway by reversing the ubiquitination
catalyzed by these ligases. In fact, ectopic expression of wild-type
USP3, but not a catalytically inactive mutant protein, prevented
accumulation of RNF168 and 53BP1 at IR-induced DNA damage
foci (IRIFs), while leaving upstream signaling through γH2AX
and RNF8 intact (Doil et al., 2009; Mosbech et al., 2013).
Notably, RNF8 also ubiquitinates non-histone proteins at DSBs
(Acs et al., 2011; Meerang et al., 2011; Mallette et al., 2012)
and RNF8-catalyzed ub conjugates distinct form H2A/H2AX are
required for RNF168 recruitment (Mattiroli et al., 2012). Given
the excess of chromatin-bound ub conjugates compared to the
increase of uH2A measured upon USP3 loss (Nicassio et al.,
2007; Lancini et al., 2014), it is conceivable that modulation
of DDR signaling by USP3 may involve deubiquitination of
additional, non-histone, targets. Because of spatial proximity,
it is possible that these other USP3 targets may include as-yet
undeﬁned RNF8 substrates and/or DDR factors, many of which
are known to be ubiquitinated, including RNF168 and 53BP1
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TABLE 1 | Mammalian DUBs that have been associated with the chromatin-based DSB response and their implications in organism physiology and
human disease.
DUB Substrate(s) Proposed role(s) in
DDR
Other cellular
functions
Implications in organism
physiology/disease
Reference
Ubiquitin specific proteases (USP)
USP3 H2A, H2AX,
H2B, RIG1
Antagonizes RNF168
IRIFs; promotes, DSB
repair,
sensitization:IR1
Cell cycle; type I
interferon signaling;
HGF-dependent
scattering response
Usp3-null mice display lymphopenia,
decline in HSC function and
spontaneous tumorigenesis upon aging
Nicassio et al. (2007), Buus et al.
(2009), Doil et al. (2009), Mosbech et al.
(2013), Cui et al. (2014), Lancini et al.
(2014), Nishi et al. (2014), Sharma et al.
(2014)
USP16/
Ubp-M
H2A2 DSB-induced gene
silencing
Cell cycle;
transcription; ESC
differentiation
Usp16 knockout is embryonic lethal.
Trisomy of Usp16 (Ts65Dn model for
Down’s syndrome) associates with
reduced HSC self-renewal
Joo et al. (2007), Shanbhag et al.
(2010), Adorno et al. (2013), Yang et al.
(2014), Zhang et al. (2014)
Dub3/
USP17L2
H2AX,
Cdc25A
Antagonizes RNF168
IRIFs
Cell cycle/DNA
damage checkpoint;
ESC self-renewal
Promotes growth of human breast
cancer xenograft tumors
Pereg et al. (2010), van der Laan et al.
(2013), Delgado-Diaz et al. (2014)
USP34 RNF168, Axin Stabilizes RNF168
protein
Wnt/beta-catenin
signaling
n.d. Lui et al. (2011), Sy et al. (2013)
USP44 H2A, H2B,
CDC20
Antagonizes RNF168
and 53BP1 IRIFs
Spindle assembly
checkpoint; prevents
aneuploidy
Usp44-null mice develop spontaneous
tumors, in particular in the lung
Stegmeier et al. (2007), Song et al.
(2010), Zhang et al. (2011, 2012),
Fuchs et al. (2012), Mosbech et al.
(2013)
Ubiquitin C-terminal hydrolases (UCH)
BAP1 H2AK119ub
H2AX
Promotes DSB repair.
Sensitization: IR and
PARP inhibitors
Cell cycle progression;
transcription
Bap1-knockout is embryonic lethal;
Bap1 deletion in adulthood results in
HSC defects and myeloid
transformation. Human tumor
suppressor
Nishikawa et al. (2009), Harbour et al.
(2010), Scheuermann et al. (2010), Bott
et al. (2011), Dey et al. (2012),
Peña-Llopis et al. (2012), Carbone et al.
(2013), Ismail et al. (2014), Nishi et al.
(2014), Yu et al. (2014)
JAMM/MPM+ metallo-proteases
BRCC36,
(BRCC3)
K63-ub,
H2A-K63-ub,
IFNAR1
Restrict DNA end
resection; limits HR.
Sensitization: IR
Interferon responses Aberrant expression in human breast
tumors
Dong et al. (2003), Sobhian et al.
(2007), Wang and Elledge (2007),
Cooper et al. (2009), Shao et al. (2009),
Coleman and Greenberg (2011), Hu
et al. (2011), Zheng et al. (2013)
MYSM1/
2A-DUB
H2A Promotes DSB repair.
Sensitization:IR1
Transcription Mysm1-null mice display partial
embryonic lethality, growth retardation,
epidermal abnormalities, multi-lineage
hematopoietic defects, HSC
deficiencies and predisposition to
lymphoma
Zhu et al. (2007), Jiang et al. (2011),
Nijnik et al. (2012), Nandakumar et al.
(2013), Wang et al. (2013), DiTommaso
et al. (2014), Liakath-Ali et al. (2014),
Nishi et al. (2014), Won et al. (2014),
Belle et al. (2015), Gatzka et al. (2015)
POH1/
PSMD14
K63-ub Restricts 53BP1;
promotes RAD51;
sensitization: IR,
cis-platin, HU
Proteasome activity n.d. Yao and Cohen (2002), Butler et al.
(2012), Kakarougkas et al. (2013)
Ovarian tumor proteases (OTU)
OTUB1 K48-ub Non-catalytical
inhibition of RNF168
and of
K63-ub-chains.
Sensitization:IR
p53 stability; TGFβ
signaling; c-IAP1
stability
n.d. Nakada et al. (2010), Juang et al.
(2012), Sun et al. (2012), Wiener et al.
(2012), Herhaus et al. (2013), Mevissen
et al. (2013)
OTUB2 L3MBTL1,
K63-ub3
Suppresses HR,
sensitization:NCS and
CPT
n.d. n.d. Kato et al. (2014)
All DUBs discussed here show certain degree of evolutionary conservation. To date, their role in DDR emerged from studies in the mammalian system or chicken DT40
cells (Yu et al., 2014). All DUBs, except for OTUB2, show sequence conservation in Xenopus laevis and in zebrafish (Danio rerio; www.ensembl.org; Tse et al., 2009).
Drosophila melanogaster orthologs of BAP1 (Calypso; Scheuermann et al., 2010), PHO1/PSMD1 (Rpn11) and USP34 (puf/puffyeye) have been described (www.ensembl.
org; Tsou et al., 2012). PHO1/PSMD1 has an ortholog in Saccharomyces cerevisiae, RPN11. The S. cerevisiae DUB closest to USP3, USP16, and USP44 is Ubp8 (www.
ensembl.org; Sloper-Mould et al., 1999), which targets yeast H2B (Henry et al., 2003). c-IAP1, cellular inhibitor of apoptosis 1; CTP, camptothecin; ESC, embryonic
stem cell; HGF, hepatocyte growth factor; HR, homologous recombination; HSC, hematopoietic stem cell; HU, hydroxyurea; IR, ionizing radiation; H2A-K63-ub, H2A
modified by lysine 63-linked ub chains; IRIFs, ionizing radiation induced foci; NCS, neocarzinostatin radiomimetic drug; PARP, poly(ADP-ribose) polymerase; IFNAR1, type
1 interferon (IFN) receptor chain 1; K48-ub, lysine 48-linked ub chains; K63-ub, lysine 63-linked ub chains DNA damage-inducing agents known to sensitize (tumor) cells
depleted for the DUB or 1DUB knockout mice are indicated; 2not H2B, not K63-ub; 3not H2A-K63-ub. n.d., not determined.
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(Gudjonsson et al., 2012; Jackson and Durocher, 2013). In this
regard, it is of note that ectopic green ﬂuorescent protein (GFP)-
USP3 fusion protein could not be detected at DNA damage
foci (Mosbech et al., 2013). While this may reﬂect detection
limitations liked to the experimental conditions, it is also possible
that USP3 may, at least in part, act in DDR through indirect
mechanisms.
USP16
By a conventional chromatography approach, USP16 (also
known as Ubp-M) was puriﬁed from HeLa cells as an enzyme
strongly active in removing the mono-ub moiety form H2A
(Joo et al., 2007). Consistently, growing evidence support a
functional role of USP16 in counteracting PcG-mediated gene
silencing through H2AK119ub deubiquitination (Joo et al., 2007;
Adorno et al., 2013; Frangini et al., 2013; Yang et al., 2014).
Local transcription inhibition also occurs in cis at the chromatin
contiguous to sites of DSB induction, a phenomenon dependent
on the ATM/RNF8/RNF168 ub pathway (Shanbhag et al., 2010)
and on RING1b/BMI1 (Kakarougkas et al., 2014; Ui et al., 2015).
Notably, siRNA-mediated knock- down of Usp16 expression
resulted in sustained DSB-induced uH2A, which prolonged
gene silencing in the proximity of the DSB (Shanbhag et al.,
2010). These ﬁndings implicate USP16 in controlling reversible
transcriptional inhibition at DSBs by removal of uH2A and place
USP16 at the interplay between DDR signaling and local gene
silencing (Shanbhag et al., 2010). Whether USP16 impacts on
DSB repair is unclear. In fact, USP16 was not readily detected at
IRIFs and its ectopic expression failed to limit 53BP1 recruitment
at DSBs (Mosbech et al., 2013; Nishi et al., 2014). Also, USP16 did
not score above signiﬁcance in a siRNA-based in vitro functional
screen for DUBs aﬀecting spontaneous DNA damage, DSB repair
or DSB-induced G2/M checkpoint (Nishi et al., 2014). Recently,
USP16 has been found to interact with HERC2 (Sowa et al.,
2009; Zhang et al., 2014), an E3 ligase known to stabilize the
RNF8 interaction with its cognate E2 ubc13 and to promote DSB
signaling (Bekker-Jensen et al., 2010). This ﬁnding puts forward
a potential mechanism through which USP16 may be implicated
in the RNF8 pathway.
USP44
Functional genetic screens ﬁrst uncovered USP44 as a
regulator of the mitotic spindle assembly checkpoint through
deubiquitination of the APC activating subunit CDC20
(Stegmeier et al., 2007; Song et al., 2010). Further establishing
USP44 function during mitosis, a genetic approach revealed
the requirement of USP44 for proper centrosome separation
and positioning, ensuring accurate chromosome segregation
(Zhang et al., 2012). More recently, an overexpression screen for
DUBs antagonizing the RNF8-RNF168 pathway was performed
in human U2OS cells. Among the 60 DUBs tested, USP44
was identiﬁed as one of the ﬁve DUBs that potently abrogate
recruitment of 53BP1 to IRIFs, along with the previously
identiﬁed USP3 (Nicassio et al., 2007; Doil et al., 2009) and
OTUB1 (Nakada et al., 2010; Mosbech et al., 2013). Consistent
with such an activity, GFP-USP44 re-localized to DNA damage
sites generated by laser micro-irradiation, in a manner dependent
on RNF8 and RNF168 (Mosbech et al., 2013; Nishi et al., 2014).
Direct reversal of H2A ubiquitination is likely one of the
inhibitory mechanisms through which USP44 opposes to
53BP1 recruitment. In fact, inducible expression of wild type
USP44 was accompanied by: (i) strong reduction of cellular
uH2A, indicating that USP44 can target the most abundant
H2AK119ub mark; (ii) reduction of mono- di- and tri-ub
H2A upon H2A co-overexpression, a condition that allows
visualization of poly-ub chains; (iii) displacement of endogenous
RNF168 from IRIFs. USP44 displays certain speciﬁcity for
histones and can target, besides uH2A, uH2B (Mosbech et al.,
2013), an activity that may also contribute to DDR (Shiloh
et al., 2011). These ﬁndings are in line with USP44 being a
chromatin-associated protein (Stegmeier et al., 2007; Fuchs
et al., 2012) and with the identiﬁcation of H2A and H2B as
signiﬁcantly enriched interactors in a proteomics survey (Sowa
et al., 2009).
Notably, USP44 shares with USP3 the ability to target both
uH2A and uH2B and to displace RNF168 and 53BP1 from
IRIFs (Nicassio et al., 2007; Doil et al., 2009; Fuchs et al.,
2012; Mosbech et al., 2013). This suggests that these DUBs may
have related/overlapping functions in DDR, a hypothesis also
supported by their clustering in phylogenetic analysis of DUBs
based on DSB repair activity (Nishi et al., 2014). One could
envisage temporal or spatial regulation of the activities of these
DUBs in relation to diﬀerent chromatin territories at the DSB
(Chapman et al., 2012; Kakarougkas et al., 2013), cell cycle or
chromatin states. It is currently not known if their eﬀects on
uH2A/uH2B are additive. USP3 knock-down alone causes a
signiﬁcant, although modest, enlargement of spontaneous and
IR induced 53BP1 foci (Nicassio et al., 2007; Gudjonsson et al.,
2012). The engagement of USP3 and USP44 potentially similar
activities at DSBs may reﬂect the need to eﬀectively control
RNF168-mediated signaling. It will be interesting to address this
interplay and to investigate how USP44 impacts on genomic
stability and cellular survival upon damage.
BAP1
The BRCA1-associated protein 1 (BAP1; also known as UCHL2)
displays DUB activity for H2AK119ub (Scheuermann et al.,
2010). BAP1 is active in the context of the PcG repressive complex
PR-DUB, an evolutionary conserved complex comprising BAP1
and additional sex combs-like 1 (ASXL1) in mammals, and
their orthologs Calypso and Asx in Drosophila (Scheuermann
et al., 2010). The Drosophila PR-DUB complex is thought to
maintain a balanced H2AK119ub status required for proper
HOX gene silencing (Scheuermann et al., 2010). Consistent
with functional conservation, BAP1 interaction with ASLX1
and functional implication in PcG target genes regulation are
documented in mammalian cells (Bott et al., 2011; Dey et al.,
2012; Peña-Llopis et al., 2012). In addition, a number of studies
implicate BAP1 in the DSB response. Indeed, shRNA-mediated
silencing/loss of Bap1 results in defective DSB repair (Nishi
et al., 2014; Yu et al., 2014) and Bap1-null cancer cell-lines
are hypersensitive to IR (Nishikawa et al., 2009; Bott et al.,
2011; Peña-Llopis et al., 2012; Ismail et al., 2014; Yu et al.,
2014). Experimental evidence of chromatin recruitment based on
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chromatin immunoprecipitation (ChIP) at I-Sce-induced breaks
(Yu et al., 2014) and visualization by microscopy at sites of micro-
irradiation (Ismail et al., 2014; Nishi et al., 2014) suggests that
BAP1 function is exerted at the chromatin ﬂanking DBSs. In fact,
enhancement of uH2A/uH2AX levels upon IR was reported upon
BAP1 depletion (Ismail et al., 2014; Yu et al., 2014). Since BAP1
is recruited to DSBs together with its PcG protein partner ASLX
(Ismail et al., 2014), one potential function of the PR-DUB might
be regulation of (PcG-mediated) transcriptional silencing at DSBs
(Shanbhag et al., 2010; Kakarougkas et al., 2014; Ui et al., 2015).
It will be interesting to further investigate the interplay between
BAP1 and the PcG repressive complexes PRC1 and PRC2 at
DBS.
Similarly to BRCA1-loss, BAP1-deﬁcient cells show
hypersensitivity to PARP inhibition, a ﬁnding that suggests
involvement of BAP1 in BRCA-mediated HR (Peña-Llopis et al.,
2012; Ismail et al., 2014; Yu et al., 2014). In support of this
hypothesis, Ismail et al. (2014) and Yu et al. (2014) reported
reduced recruitment of BRCA1 and of key HR factors such as
RAD51 and RPA at damage sites, concomitant with defective HR.
The cellular interplay between BAP1 and BRCA1 is, however,
far from being understood. On one hand, BAP1 was ﬁrst
discovered in a yeast two-hybrid screen as a BRCA1-interacting
protein (Jensen et al., 1998). On the other, proteomic studies
in human/mouse cells did not detect BAP1 in stable complex
with BRCA1 (Sowa et al., 2009; Bott et al., 2011; Dey et al.,
2012). In vitro, BAP1 antagonizes the ub ligase activity of the
BRCA1/BARD1 complex (Nishikawa et al., 2009), this being
the E3 complex with DDR functions (Greenberg et al., 2006).
If this would hold in vivo, BAP1 may be important to regulate
BRCA1/BARD1 activity and/or it may target putative/yet-
undeﬁned BRCA1 substrates during DDR (Kalb et al., 2014).
Identiﬁcations of BAP1 targets during DDR will aid in clarifying
whether BAP1-mediated regulation of BRCA1 activity is a
mechanism to control HR.
Further, connecting BAP1 to PARP, it is of note that
recruitment of GFP-BAP1 to laser-induced DSBs requires PARP
activity, beside RNF8/RNF168 (Ismail et al., 2014). However,
since BAP1 does not seem to bind directly to poly(ADP)
ribose (PAR) polymers, PARP eﬀect on BAP1 in DDR has
been suggested to be indirect (Ismail et al., 2014). PARP has
been reported to promote RNF168-mediated DDR signaling and
repair (Smeenk et al., 2013), as well as it has been implicated
in favoring recruitment of PcG proteins (MEL18 and CBX4) to
DSBs (Chou et al., 2010). Also, the RNF8-related E3 CHFR,which
appears to regulate the ﬁrst wave of ubiquitination, requires PAR
for its rapid recruitment to DSBs (Liu et al., 2013). Most likely,
the link between PARP and BAP1 in DDR is among one of these
activities.
MYSM1/2A-DUB
The metalloprotease MYSM1 (also known as 2A-DUB)
deubiquitinates uH2A in vitro and in cell lines (Zhu et al.,
2007). Although it was originally identiﬁed as a transcriptional
co-activator (Zhu et al., 2007), recent ﬁndings connect this DUB
to DDR. MYSM1 has a distinctive domain architecture among
the DUBs, harboring a SANT and SWIRM domains, which are
frequently found in transcription factors and in DNA/chromatin-
associated proteins (Boyer et al., 2004; Yoneyama et al., 2007).
Consistently, ChIP assays detected enrichment of MYSM1 at
numerous gene promoters (Zhu et al., 2007; Jiang et al., 2011;
Wang et al., 2013). Interestingly, MYSM1 is also capable of
binding to DSBs ﬂanking chromatin, where it may favor repair
(Nishi et al., 2014). Further linking MYSM1 to DDR, MYSM1
was identiﬁed as an ATM phosphorylation target upon damage
(Matsuoka et al., 2007) and its deletion in mice confers sensitivity
to total body IR (Wang et al., 2013). Spontaneous DNA damage
may also be enhanced upon MYSM1 loss, as measured by
increased γH2AX staining, micronuclei and oxidative stress
in hematopoietic populations of MYSM-deﬁcient mice (Nijnik
et al., 2012; Gatzka et al., 2015). Yet, MYSM1 involvement in
DDR and more speciﬁcally in the RNF8 pathway remains largely
unexplored. MYSM1 activity has been mostly linked to the
repressive mark H2AK119ub (Zhu et al., 2007; Jiang et al., 2011;
Wang et al., 2013; Won et al., 2014), opening the possibility
of MYSM1 participation in regulating DSB-induced gene
silencing. Also, rather than targeting the DDR H2AK13/15ub
mark (Mosbech et al., 2013), MYSM1 may, similarly to other
JAMM/MPN+ metalloproteases (see below), display speciﬁcity
for Lys63-linked ub chains (Komander et al., 2009), which are
key DDR signals.
Finally, with regards to H2A DUBs, another DUB that
has been reported to oppose to H2AX ubiquitination, thereby
preventing recruitment of both 53BP1 and BRCA1 to DSBs is
DUB3 (Delgado-Diaz et al., 2014). At least ﬁve additional DUBs
can limit RNF8-RNF168-mediated chromatin ubiquitination.
These DUBs are more extensively reviewed elsewhere (Jackson
and Durocher, 2013; Panier and Durocher, 2013). Among
these, BRCC36 (BRCC3), POH1/PSMD14 and OTUB1 directly
target ub conjugates on chromatin. The JAMM/MPN(+) DUBs
BRCC36 (BRCC3; Dong et al., 2003; Sobhian et al., 2007;
Shao et al., 2009) and POH1/PSMD14 (Butler et al., 2012) act
as negative regulators by displaying selectivity for K63-ub at
DSBs. BRCC36 is part of the BRCA1-A complex and, together
with Rap80, has been associated with inhibition of HR early
upon DSB induction (Coleman and Greenberg, 2011; Hu et al.,
2011). On the other hand, one of the reported functions of the
19S proteasome subunit POH1 is to promote HR, supporting
contribution of DUB activity to DSB repair pathway choice
(Butler et al., 2012; Kakarougkas et al., 2013). Further in line with
such hypothesis, depletion of the otubain family DUB OTUB2
resulted in decreased HR, as measured by the DR-GFP HR
reporter assay (Kato et al., 2014). OTUB2 is thought to act early
after damage by preventing RNF8-mediated ubiquitination of
L3MBTL1, which proteasomal degradation is required for 53BP1
recruitment (Acs et al., 2011), as well as K63-ub (Kato et al.,
2014). However, unlike for BRCC36, these K63-ub-conjugates
do not include H2A, indicating the ability of these DUBs to
target diﬀerential substrates (Shao et al., 2009; Kato et al., 2014).
Notably, the DUBs OTUB1 and USP34 regulate DDR through
indirect mechanisms. In fact, OTUB1 attenuates ub-based DDR
through non-catalytic inhibition of RNF168 activity (Nakada
et al., 2010). Instead, USP34 acts on RNF168 by removing
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degradative ub chains, thereby stabilizing the E3 and promoting
DDR signaling (Sy et al., 2013). Also, indirect eﬀects may underlie
USP11 regulatory activity in HR (Wiltshire et al., 2010). Finally,
USP28 is one more USP recruited via 53BP1 to DSBs. However,
loss of USP28 did not cause signiﬁcant DDR defects nor an
altered phenotype in mice, indicating that this DUB does not
have a prominent role in the DSB response (Knobel et al.,
2014).
The substrate selectivity of the DUBs is critical is regulating
DDR, given the diversity of ub signals at DSBs. Yet, how the
DSB-associated H2A DUBs reach selectivity for H2AK119ub
or H2AK13/15ub and if any of these DUBs can speciﬁcally
oppose the DSB-induced H2AK13/15ub mark is still an open
question. USP3 and USP44 potent activity toward steady state
uH2A and their ability to limit 53BP1 IRIFs suggest that these
DUBs can potentially target both the PcG-speciﬁc K119ub as
well as the DDR-mediated K13/15ub marks on H2A (Nicassio
et al., 2007; Doil et al., 2009; Mosbech et al., 2013; Sharma
et al., 2014), the latter being a prerequisite for 53BP1 binding at
damage sites (Fradet-Turcotte et al., 2013). Instead, USP16, BAP1
and MYSM1, lacking clear impact on 53BP1 IRIFs (Mosbech
et al., 2013), may not be directly involved in H2AK13/15ub
deubiquitination.
Notably, chromatin states are expected to impact on the
recruitment/activity of the DUBs. In fact, MYSM1, which is
found in complex with the histone acetyl transferase p/CAF,
has been reported to be more active toward hyperacetylated
nucleosomal substrates (Zhu et al., 2007). Also, recent ChIP-
sequencing approaches indicate that active transcription marks,
such as H3K36Me3, specify the recruitment of HR proteins to
DSBs (Aymard et al., 2014), and readers of acetylated chromatin
(bromodomain containing proteins) re-localize to DNA damage
sites to promote gene silencing and repair by HR (Gong et al.,
2015).
As to the “ubiquitin code,” it is likely that, besides K48-,
K63- and the less characterized K6-linked ub chains (Morris and
Solomon, 2004), additional “atypical” ub polymers (Kulathu and
Komander, 2012) participate in DSB signaling. Such examples
are the recently reported K27-linked ub chains catalyzed by
RNF168 on H2A/H2AX (Gatti et al., 2015). Also, K27-ub
might be relevant for PcG-mediated DDR, as auto-ubiquitination
of RING1B through mixed polyub chains (K6-K27-K48) is a
prerequisite for its ability to mono-ubiquitinate H2A in vitro
(Ben-Saadon et al., 2006). While a few DDR DUBs display ub-
linkage selectivity, such as the JAMM proteases BRCC36 and
POH1 for K63-ub, OTUB1 for K48-ub and OTUB2 for K63-
ub (Butler et al., 2012; Komander and Rape, 2012; Mevissen
et al., 2013; Kato et al., 2014), the ub-linkage selectivity
of many other (DDR) DUBs is unclear. Potentially, DUBs
belonging to the USP family can hydrolyze all linkages, al
least when synthetic ub dimers are used as substrates in vitro
(Faesen et al., 2011). Elucidation of DUB selectivity/regulation
of activity in DDR awaits dedicated cell-based as well as
in vitro assays, for example employing relevant substrates
such as nucleosomal particles and (DDR-) speciﬁc E3/E2
ligases.
Finally, the ability to deubiquitinate multiple substrates is
common within DUBs and the low degree of selectivity shown
by the USPs in vitro suggests that other mechanisms rather
than molecular substrate selection (i.e., regulation by cofactors,
post-translational modiﬁcations, subcellular localization, cell
cycle regulation) may have a greater role in determining their
speciﬁcity in vivo (Komander et al., 2009; Clague et al., 2012;
Sahtoe and Sixma, 2015). Indeed, for instance, BAP1 fails
to deubiquitinate H2A if not in the context of the PR-DUB
(Scheuermann et al., 2010). Similarly, the JAMM proteases
POH1 and BRCC36 require protein–protein interactions for
DUB activity and BRCC36 is targeted in the nucleus to DSBs or
to cytoplasmatic functions by diﬀerential association with RAP80
or SHMT respectively (Cooper et al., 2009; Zheng et al., 2013).
The use of catalytically inactivemutants that allows to circumvent
the transient nature of the DUB/substrate interaction (Nicassio
et al., 2007; Sowa et al., 2009), and conditions of DNA damage in
proteomic approaches may help toward the identiﬁcation of DUB
targets/cofactors relevant for DSB signaling.
DSBs-Associated DUBs: Implications in
Stem Cell Maintenance and in Cancer
De-regulation of DDR mechanisms can contribute to cancer
but may also promote functional decline of the stem cells with
consequential deterioration in tissue function and aging (Jackson
and Bartek, 2009; Blanpain et al., 2011; Behrens et al., 2014).
Consistent with this, recent studies uncovered the relevance of
DSB-associated DUBs in preserving tissue function. Here, I will
focus on the emerging roles of the H2A DUBs USP3, USP16,
USP44, BAP1, andMYSM1 in HSCmaintenance and cancer. The
direct investigation of the consequences of inactivation of some
of these DUBs has been so far restricted to HSCs for practical
reasons. However, the recent advances in our understanding of
stem cell niches in several organs warrant extending these studies
to other tissues, which might uncover unique dependencies for
individual components of the pathway.
DSBs-Associated DUBs in Hematopoietic
Stem Cell Biology
Hematopoietic stem cells maintain homeostasis and replenish
the blood system throughout life, by their ability to self-renew.
DNA damage accumulates in HSCs during aging in mice and in
man (Rossi et al., 2007; Rübe et al., 2011; Beerman et al., 2014),
and it has become clear that genome repair is important for the
HSC regenerative potential. In fact, DNA damage to the HSC
pool has been identiﬁed as an underlying cause of BM failure in
patients suﬀering from FA, an inherited DNA repair deﬁciency
syndrome (Ceccaldi et al., 2012). In particular, a strong p53
response to replication stress and unresolved DNA damage was
characterized as a critical mechanism for the progressive loss of
HSCs and hence BM failure in FA patients (Ceccaldi et al., 2012).
Further supporting a crucial role of DDR in HSC homeostasis,
mouse models with engineered mutations in diﬀerent DNA
repair and DDR genes, besides FA related genes, manifest severe
hematopoietic phenotypes and HSC deﬁciencies, in particular
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under conditions of stress (Ito et al., 2004; Nijnik et al., 2007;
Rossi et al., 2007; Niedernhofer, 2008; Garaycoechea et al., 2012;
Wang et al., 2012; Walter et al., 2015).
DNA damage, such as damage arising from ineﬃcient DNA
replication or from reactive oxygen species (ROS) and DSBs, can
have two major consequences in HSCs. First, unrepaired DSBs
may drive HSCs cell cycle arrest, senescence or apoptosis, or
premature diﬀerentiation leading to their loss of function and
consequent aging phenotypes and organ failure (Wang et al.,
2012; Flach et al., 2014). Second, the accumulation of mutations
providing selective advantage to the mutated cells can lead
to cancer, as exempliﬁed in myelodysplastic syndrome (MDS)
and myelogenous leukemias (Blanpain et al., 2011; Behrens
et al., 2014). Notably, the consequences of chronic genotoxic
stress/persistent DNA damage signaling are mostly evident in
tissues with high cell turnover and relying upon expansion
of a limited number of stem/precursors cells, such as the
hematopoietic system (Bender, 2002; Rossi et al., 2007). This
makes the hematopoietic system potentially sensitive to even
modest alterations in the ub-equilibrium in homeostasis as well as
during ub-mediated DDR. An example in this direction is given
by deletion of the DUB USP1 in mice. USP1 is a regulator of
DNA-interstrand cross-links repair by the FA pathway through
deubiquitination of one of its critical factor at the chromatin,
FANCD2 (Kim et al., 2010). Consistent with such a role,
USP1 deletion reduces the repopulation abilities of mouse HSCs
(Parmar et al., 2010).
A link between the ub-based response to DSBs and HSC
maintenance emerged from recent in vivo studies on USP3.
Indeed, a clear pathological manifestation of Usp3 deletion in
mice is progressive lymphopenia upon aging (Lancini et al.,
2014). Such an altered lineage potential and immunodeﬁciency
occur in the elderly and it has been linked to an impaired
functional capacity of the aged HSCs (Geiger et al., 2013).
Consistently with an age-dependent cellular attrition, USP3-
deﬁcient HSCs displayed a marked decline in cell number
and activity over time, as demonstrated in BM transplantation
experiments (Lancini et al., 2014). Is this phenotype related to
DNA damage? In support of this hypothesis, we found that
USP3-deﬁcient HSCs accumulate spontaneous DNA damage,
are hypersensitive to IR in vivo and ineﬃciently resolve 53BP1
IRIFs and DSBs in vitro (Lancini et al., 2014). Collectively,
these data suggest a role for USP3 in protecting the HSCs
from DNA damage by restraining the ub-dependent DDR
pathway (Lancini et al., 2014). Yet, the source of spontaneous
DNA damage measured in USP3-deﬁcient HSCs has not been
identiﬁed. In absence of direct evidences, replication-associated
genotoxic stress, which is thought to potently contribute to
normal HSC decline during aging (Flach et al., 2014), may
certainly be an accountable one. In fact, young USP3 knockout
BM performed poorly in serial transplantations, a situation of
enforced proliferation resembling what happens during aging
(Lancini et al., 2014).
In line with an involvement of the RNF8-RNF168 pathway
in hematopoiesis, inactivating mutations in RNF168 are
associated with the RIDDLE syndrome, characterized by cellular
radiosensitivity and immunodeﬁciency (Stewart et al., 2009),
features which are recapitulated in knockout mouse models
for these E3s (Li et al., 2010; Santos et al., 2010; Bohgaki et al.,
2011). Whether RNF8/RNF168 deﬁciency also impact on HSC
maintenance has not been reported, yet signiﬁcant reduction of
BM cellularity was measured upon RNF8 loss (Li et al., 2010).
USP3 as well as RNF8 and RNF168-deﬁcient mice constitute
valuable in vivo models to gain insights into how lack of control
of the ub-dependent DDR pathway may contribute to the
functional decline observed in aged HSCs.
The Usp16 gene is located on human chromosome 21, a
chromosome that is triplicated in Down’s syndrome. Trisomy
of Usp16 was recently associated with reduced HSC self-renewal
in a mouse model for Down’s syndrome (Ts65Dn), whose
HSCs express 1.5-fold higher levels of Usp16 mRNA than wild
type HSCs (Adorno et al., 2013). USP16 can deubiquitinate
H2AK119ub (Joo et al., 2007), a critical mark for epigenetic
control of stem-cell identity/maintenance and diﬀerentiation by
the PcG E3 RING1B/BMI1 (Sparmann and van Lohuizen, 2006;
Di Croce and Helin, 2013). Relevant to this review, BMI1 is
essential to HSC self-renewal through mechanisms involving
repression of the Cdkn2a tumor suppressor locus as well as
protection from oxidative stress and DNA damage (Lessard and
Sauvageau, 2003; Park et al., 2003; Liu et al., 2009). Notably,
Adorno et al. (2013) linked increased Usp16 gene dosage with
reduced H2A ubiquitination at the Cdkn2a locus and with a
concomitant increase in senescence of Ts65Dn ﬁbroblasts. This
suggests that Usp16 trisomy contributes, at least in part, to
the cellular defects of Ts65Dn mice through modulation of the
BMI1 self-renewal and/or senescence pathway (Adorno et al.,
2013). Increased ROS and markers of oxidative stress were
also reported in Ts65Dn hematopoietic stem and progenitor
cells (HSPCs) (Lorenzo et al., 2011). It will be interesting to
investigate whether Usp16 trisomy contributes to this phenotype
and whether Ts65Dn HSCs/ﬁbroblasts suﬀer from augmented
DNA damage/ DDR defects.
MYSM1, ﬁrst linked to epigenetic control of B-cell
development in mice (Jiang et al., 2011), recently emerged
as a critical regulator of hematopoiesis. Notably, beside distinct
multi-lineage defects in hematopoietic cell diﬀerentiation (Jiang
et al., 2011; Nijnik et al., 2012; Nandakumar et al., 2013; Won
et al., 2014), loss of MYSM1 in mice results in severe reduction of
the HSC pool size and impairment in their in vivo repopulation
capacity (Nijnik et al., 2012; Wang et al., 2013). While relative
limited transcriptional changes were detected in Mysm1-null
compared to wild type HSPCs, Gﬁ1, one of the critical HSC
factors, was identiﬁed as potential target for MYSM1-mediated
epigenetic regulation (Wang et al., 2013). A consistent feature
of Mysm1-null HSPCs that likely contributes to their reduced
cellularity is an elevated apoptosis rate, accompanied by elevated
ROS and γH2AX (Nijnik et al., 2012; Wang et al., 2013; Gatzka
et al., 2015). Oxidative stress, accumulation of DNA damage and
p53 activation are frequently associated with HSC deﬁciency
and BM failure syndromes (Ito et al., 2004; Niedernhofer, 2008;
Liu et al., 2009; Ceccaldi et al., 2012). Consistently, upregulation
of p53 and of pro-apoptotic p53 target genes was measured in
MYSM1-deﬁcient cells (Nijnik et al., 2012; Belle et al., 2015;
Gatzka et al., 2015) and p53 co-deletion signiﬁcantly rescued
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HSCs numbers and activity in Mysm1-/-; p53-/- double mutant
mice (Belle et al., 2015; Gatzka et al., 2015). As mentioned
before, BMI1 plays a crucial role in protecting mouse cells,
including HSCs, from mitochondrial dysfunction, ROS and
DNA damage (Liu et al., 2009). Intriguingly, however, while
antioxidants could rescue Bmi1-/- mice (Liu et al., 2009), similar
treatments did not rescue Mysm1-/- mice developmental and
hematopoietic phenotypes, suggesting that mechanisms other
that oxidative stress may contribute to p53 activation in the
context of MYSM1 loss (Belle et al., 2015). Further investigation
of such p53-inducing cellular stresses and of MYSM1 links with
DDR merits further studies. Perhaps relevant in this regard,
Wang et al. (2013) reported exit from homeostatic quiescence for
Mysm1-/- HSCs, a condition recently suggested to induce DNA
damage and attrition in HSCs upon a range of physiological
stresses (Walter et al., 2015). Notably, a homozygous truncating
mutation in the MYSM1 gene was reported in two young
siblings suﬀering form anemia, mild thrombocytopenia and
lymphopenia, underlying its relevance in inherited BM failure
disorders (Alsultan et al., 2013). Finally, induction and repair of
programmed DSBs by NHEJ is a physiological process crucial for
immune cells development (Alt et al., 2013). Whether DSB repair
defects contribute to the developmental deﬁciencies reported in
MYSM1-deﬁcient B and T cells (Jiang et al., 2011; Nijnik et al.,
2012; Gatzka et al., 2015) represent an interesting question for
future investigation.
Dey et al. (2012) uncovered a novel role of BAP1 in
HSC homeostasis. Indeed, BAP1 is expressed in the murine
HSPC compartment and its deletion in adulthood resulted
in skewing of diﬀerentiation toward the myeloid lineage and
decreased HSC survival/self-renewal. BAP1 involvement in HSC
function is intriguing and the eﬀect of BAP1 loss on HSC
quiescence, cell cycle progression and proliferative capacity
warrant further investigation. While several genes including
regulators of hematopoietic cell survival were identiﬁed as
potential BAP1 targets in mouse HSPCs (Dey et al., 2012), it
will be informative to address whether BAP1-deﬁcient HSCs
experience exacerbated DNA replication stress/DNA damage
and/or DDR defects, which might contribute to their functional
decline.
DSBs-Associated DUBs in Cancer
The importance of some of the previously mentioned factors
in human cancer (e.g., BRCA1, 53BP1) underscores the impact
of this pathway on human health (Jackson and Bartek, 2009;
Gudjonsson et al., 2012). The analysis of RNF8- and RNF168-
deﬁcient mice further supports a role of these key E3 ligases
in tumor suppression (Li et al., 2010; Bohgaki et al., 2011).
Notably, analogously to RNF8, Usp3-deleted mice develop a
broad spectrum of tumor types with a latency of 1 year of age
(Lancini et al., 2014). Such broad spontaneous neoplasia in USP3-
deﬁcient mice might be linked to enhanced genomic instability,
as observed in primary MEFs form these animals (Lancini
et al., 2014). Further, MYSM1-deﬁcient mice are tumor prone,
developing thymic lymphoma with a latency of 4–6months (Belle
et al., 2015). Deletion ofUsp16 in mice is instead early embryonic
lethal and the consequences of its inactivation in adult tissues
have not been explored (Yang et al., 2014). I will next focus on
USP44 and BAP1, which have been best characterized as tumor
suppressors in human pathology.
USP44 knockout mice are prone to develop spontaneous
tumors, displaying in particular an approximately nine-fold
increase in adenomas of the lung compared to wild type upon
aging (Zhang et al., 2012). Notably, USP44 was also found
frequently down-regulated in human bronchial adenocarcinomas
and patients with low USP44 expression had signiﬁcantly
shorter overall survival, underscoring a tumor suppressive
function in human cancer (Zhang et al., 2012). Zhang et al.
(2012) reported that mouse cells lacking USP44 not only show
a defect in silencing the mitotic checkpoint, a ﬂaw linked
to its deubiquitination activity toward the APC activating
subunit CDC20 (Stegmeier et al., 2007), but they mis-
segregate their chromosomes and exhibit whole chromosome
aneuploidy (Zhang et al., 2012). These ﬁndings suggest that
one mechanism by which USP44 suppresses tumorigenesis
is by preventing aneuploidy, a feature commonly associated
with human cancer (Zhang et al., 2012). Given USP44
novel implication in the control of DSB-induced chromatin
ubiquitination, it is plausible that DDR defects may contribute
to genomic instability and to the tumor prone phenotype of
Usp44-/- mice (Mosbech et al., 2013). Moreover, USP44 has been
reported to regulate gene expression and to prevent embryonic
stem cell diﬀerentiation through H2B deubiquitination (Fuchs
et al., 2012). It will be important to determine which of
the functions of USP44 are critically required for tumor
suppression.
BAP1 is an established tumor suppressor, with its genomic
locus being frequently deleted in human cancer. In particular,
prevalent somatic and germline BAP1 loss/inactivating mutations
are found in metastatic uveal melanomas, malignant pleural
mesothelioma and renal cell carcinomas (Harbour et al., 2010;
Bott et al., 2011; Peña-Llopis et al., 2012; Carbone et al., 2013).
The recent studies by Dey et al. (2012) revealed a potent
tumor suppressive function of BAP1 also in myeloid neoplasia.
This is supported by the observation that speciﬁc loss of
Bap1 in mouse hematopoietic progenitors is suﬃcient for the
propagation of features of human MDS upon transplantation
and by the identiﬁcation of de novo BAP1 mutations in MDS
patients (Dey et al., 2012). The exact mechanism through
which BAP1 regulates cell proliferation and tumorigenesis is
not known and deciphering BAP1 functions is complicated
by the diversity of protein (complexes) BAP1 interacts with in
mammalian cells, these including PcG repressors (Bott et al.,
2011; Dey et al., 2012; Peña-Llopis et al., 2012). Collectively,
however, the current data based on quantitative analysis of
BAP1 protein interactions and target genes identiﬁcation
implicate transcriptional de-regulation in the pathogenesis
of BAP1-associated mesothelioma, renal cancer and myeloid
neoplasia (Bott et al., 2011; Dey et al., 2012; Peña-Llopis
et al., 2012). Consistently with a BAP1/PR-DUB functional
role in PcG-mediated repression in Drosophila (Scheuermann
et al., 2010), the complex BAP1-associated transcriptional
network in mammals includes expression programs regulated
by PcG proteins (Bott et al., 2011; Dey et al., 2012;
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Peña-Llopis et al., 2012), the genetic alteration of which
predisposes to the development of various cancers (Sparmann
and van Lohuizen, 2006; Di Croce and Helin, 2013).
As previously discussed, BAP1-deﬁcient cancer cell lines were
shown to be more sensitive to IR and to PARP inhibitors (Peña-
Llopis et al., 2012; Ismail et al., 2014). Restoration with wild
type BAP1, but not with catalytically inactive BAP1 or with
mutant BAP1 mimicking cancer-associated mutations, protects
the cells against genotoxic death (Peña-Llopis et al., 2012;
Ismail et al., 2014). These studies indicates faults in DDR
upon BAP1 loss and provide a platform to further investigate
how (cancer-)inactivating mutations may aﬀect BAP1-mediated
DDR signaling/DSB repair and thereby contribute to tumor
suppression. Of note, BAP1 is a substrate of the ATM/ATR
checkpoint kinases, and it is phosphorylated upon several
stressors, including IR, UV light and replication stress (Matsuoka
et al., 2007; Eletr et al., 2013; Ismail et al., 2014; Yu et al., 2014).
Therefore, pleotropic eﬀects of BAP1 in DDR pathways can be
expected.
Given the multiple roles of uH2A, the consequences of
deregulation of H2A targeting DUBs in vivo are complex and the
ﬁeld is confronted with the challenge of dissecting the molecular
mechanisms involved. USP3 has been mainly linked to the DDR
and does not appear to have a prominent role in gene expression
(Lancini et al., 2014). Instead, while it is clear that USP16, BAP1,
and MYSM1 can regulate gene transcription of, among others,
PcG targets (Joo et al., 2007; Bott et al., 2011; Dey et al., 2012;
Nijnik et al., 2012; Peña-Llopis et al., 2012; Adorno et al., 2013;
Wang et al., 2013; Yang et al., 2014), the involvement of these
DUBs in DDR has just emerged and the mechanism by which
they contribute to genome stability is an important area for future
studies.
Another critical question is the relevance of DDR-DUBs for
human cancer. As discussed earlier, BAP1 is an established
tumor suppressor in man. Also, Dub3 has oncogenic potential,
a function that has been primarily related to its ability to regulate
the crucial cell cycle regulator Cdc25A phosphatase (Pereg et al.,
2010). As to the other DUBs discussed in this Review, cross-
cancer genetic alterations of the H2A-DUBs USP3, USP16,
USP44 and MYSM1, as well as for BRCC36, OTUB1, OTUB2
have been reported (cBio Portal for cancer genomics, http://www.
cbioportal.org/index.do; Dong et al., 2003). However, the role of
these DUBs in human cancer remains to be elucidated.
Finally, RNF8/RNF168 ampliﬁcation is frequently found in
human tumors (TCGA, 2012) and RNF168 gain of function was
connected with human papillomavirus (HPV)-positive cervical
cancers (Gudjonsson et al., 2012). Lack of control of ub-mediated
DDR signaling is a threat to genome integrity, and so potentially
oncogenic, for instance during mitosis (Orthwein et al., 2014)
and at telomeres, where the RNF8 pathway promotes illegitimate
repair of chromosome ends (Peuscher and Jacobs, 2011). Notably,
the role of DUBs in physiological inhibition of the RNF8 pathway
at telomeres is emerging, with BRCC36 opposing to RNF168 to
suppress chromosome end-to-end fusions (Okamoto et al., 2013).
Concluding Remarks
While it is clear that DUBs are critical regulators of the DSB
response, we are only beginning to understand their molecular
mechanisms of action, the consequences of their deregulation
on genomic stability and their impact on organism physiology
and human disease. A key unresolved question is the functional
and molecular interplay between the DUBs in determining the
ub-DDR cascade. Indeed, cooperation between DUBs-regulated
functions likely occurs, and given the potential of functional
compensation in vivo, such crosstalk is critical for genome
maintenance and cell fate outcomes (Gudjonsson et al., 2012;
Mosbech et al., 2013; Lancini et al., 2014; Nishi et al., 2014).
Small-molecule inhibitors to DUBs are being developed with
important achievements (Ernst et al., 2013; Jacq et al., 2013;
Zhang and Sidhu, 2014). Gaining insights into DUBs functional
roles and molecular networks in the DSB response could provide
novel rationale for pursuing dedicated DUBs as drug targets.
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